Arteris, Inc. (AIP) Research
Arteris, Inc. specializes in delivering intellectual property (IP) for semiconductor interconnects and comprehensive IP deployment solutions to customers across the Americas, Asia Pacific, Europe, and the Middle East. The company's core business involves the development, licensing, and support of advanced on-chip interconnect fabric technology, which is fundamental to System-on-Chip (SoC) designs and Network-on-Chip (NoC) interconnect IP. Their extensive product lineup features FlexNoC, a thoroughly validated interconnect IP, complemented by the FlexNoC Resilience Package, designed to ensure robust on-chip data protection. Ncore is another key offering, providing cache-coherent interconnect IP known for its scalability, configurability, and efficient use of silicon real estate. Additionally, Arteris provides CodaCache, an IP solution for last-level caches, and the Physical interconnect aware NoC optimizer, a software utility that estimates physical layout impacts during the early architecture and logic development stages of an SoC interconnect design. Further specialized solutions include FlexWay for IP subsystem connectivity, FlexPSI for all-digital inter-chip links, and FlexNoC Physical, which bridges physical placement and routing tools. Beyond core IP, Arteris offers a suite of IP deployment software, encompassing tools for specification, design, documentation, AI package integration, design data intelligence, and harmony trace. The company's technology is adopted by clients in a diverse range of critical sectors, including automotive, artificial intelligence (AI) and machine learning, 5G and wireless communications, data centers, and consumer electronics. Established in 2003, Arteris, Inc. is headquartered in Campbell, California.
Market snapshot
- Symbol
- AIP
- Price
- $44.11
- Day change
- +4.67%
- Market cap
- $2.0B
- P/E ratio
- -58.09x
- 52-week range
- 8.101-44.94
- Sector
- Technology
- Industry
- Semiconductors
- Next earnings
- in 2 months
- Analyst price target
- $36.50
Recent news
- Arteris Stock Surges After Q1 Earnings Exceed Expectations
Arteris Inc (NASDAQ:AIP) shares are rising in extended trading on Tuesday after the company reported better-than-expected results for the first quarter. Here's what you need to know from the report.
- AIP to take Avanos Medical private in a deal valued at about $1.27 billion
Avanos Medical said on Tuesday it has agreed to be bought by affiliates of American Industrial Partners (AIP) in an all-cash deal worth about $1.27 billion.
Peer companies
Recent insider activity
- Moll Laurent R — S-Sale (39541 shares) on 2026-06-16
- JANAC K CHARLES — S-Sale (42449 shares) on 2026-06-08
- JANAC K CHARLES — S-Sale (27551 shares) on 2026-06-08
- Bayview Legacy, LLC — S-Sale (42449 shares) on 2026-06-08
- Bayview Legacy, LLC — S-Sale (27551 shares) on 2026-06-08
Open Arteris, Inc. (AIP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.